currency tokens Block

GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.Xinxiangwei: Shareholder Xinyu Yijiade intends to reduce its shareholding by no more than 1%. Xinxiangwei announced that as of the disclosure date, Shareholder Xinyu Yijiade holds 20,175,800 shares of the company, accounting for 4.39% of the company's total share capital. Xinyu Yijiade plans to reduce the number of shares of the company by no more than 4,595,300 shares through centralized bidding or block trading of Shanghai Stock Exchange within 90 days after 15 trading days from the date of announcement, and the proportion of reduced shares in the company's total share capital is no more than 1%.During the battle of AI glasses, several new financings were under way in the field of AI glasses, among which Viture, which focuses on AR game scenes, and Even Realities, whose current product form is mainly a combination of AI and AR, have entered the late stage of the transaction, and their latest valuations both exceed 100 million US dollars. It is understood that Wang Huiwen, co-founder of Meituan, also recently invested in Viture. The old shareholders of this company founded in 2021 include Lanchi Venture Capital, BAI Capital and Zhenzhi Venture Capital. (latepost)

Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.US official-designate: The House panel will consider relaxing supervision and cryptocurrency structure. On Friday, Congressman Francci Hill, who will be the incoming chairman of the US House Financial Services Committee, said that the committee will focus on relaxing bank supervision, solving the problem of capital formation, so that more companies can go public, and solving the market structure of cryptocurrency. Hill also said in an interview that he has not yet decided whether the United States should establish a bitcoin reserve.During the battle of AI glasses, several new financings were under way in the field of AI glasses, among which Viture, which focuses on AR game scenes, and Even Realities, whose current product form is mainly a combination of AI and AR, have entered the late stage of the transaction, and their latest valuations both exceed 100 million US dollars. It is understood that Wang Huiwen, co-founder of Meituan, also recently invested in Viture. The old shareholders of this company founded in 2021 include Lanchi Venture Capital, BAI Capital and Zhenzhi Venture Capital. (latepost)

Market News: Austria provides 1,000 euros to Syrian refugees to help them return home.Guangzhou Institute: Make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. With the rapid development of polysilicon industry, the relationship between supply and demand changes rapidly and the price fluctuates greatly due to various factors such as industrial policy, production cycle and technological progress. Due to the lack of objective and continuous price signals, the polysilicon industry has concentrated capacity investment and construction, which is prone to problems such as staged supply and demand mismatch, which is not conducive to the healthy and stable development of the industry. In this context, photovoltaic industry chain enterprises have increasingly strong demands for listed polysilicon futures, pricing with futures tools and managing risks. At the same time, the listed polysilicon futures will help to export the international pricing benchmark, form the "China" price of polysilicon international trade reflecting China's industrial volume, and gradually enhance China's influence in polysilicon international trade pricing. The insiders believe that at present, the industrial silicon varieties in Guangzhou have been running smoothly for nearly two years, and the listing of polysilicon varieties will further improve the variety layout of the crystalline silicon industrial chain for futures services, and provide more accurate futures tools for polysilicon and its downstream photovoltaic industrial chain, which is conducive to further consolidating the global competitive advantage of China's photovoltaic and other industries. The relevant person in charge of the Guangzhou Stock Exchange said that in the next step, under the guidance of the China Securities Regulatory Commission, the Guangzhou Stock Exchange will make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. (Guangzhou Institute)China International Economic Exchange Center held the annual economic conference in China on December 14th, attended by Han Wenxiu of China Finance Office, and the annual economic conference in China on December 14th, with the theme of implementing the spirit of the Central Economic Work Conference and promoting sustained economic recovery. Han Wenxiu from Zhongcai Office, Zhao Chenxin, Deputy Director of National Development and Reform Commission, Sheng Qiuping, Vice Minister of Commerce, and Wang xin, Director of Research Bureau of China People's Bank will give keynote speeches. (China International Economic Exchange Center)